Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02340780 |
| Title | Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | NCIC Clinical Trials Group |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Tom Baker Cancer Centre | Calgary | Alberta | T2N 4N2 | Canada | Details | |
| Cross Cancer Institute | Edmonton | Alberta | T6G 1Z2 | Canada | Details | |
| CancerCare Manitoba | Winnipeg | Manitoba | R3E 0V9 | Canada | Details | |
| QEII Health Sciences Centre | Halifax | Nova Scotia | B3H 1V7 | Canada | Details | |
| University Health Network | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| The Jewish General Hospital | Montreal | Quebec | H3T 1E2 | Canada | Details |